Yr Athro Sailesh Kotecha

2026

• Moore, H. L. et al., 2026. Data collection and harmonization in preterm respiratory research: recommendations and insights from PELICAN. Pediatric Pulmonology 61 (9) e71812. (10.1002/ppul.71812)
• Course, C. W. and Kotecha, S. 2026. Improving the follow-up of children and adults with prematurity-associated lung disease. Expert Review of Respiratory Medicine (10.1080/17476348.2026.2699460)
• Berry, C. D. et al., 2026. Long-term respiratory outcomes of infants born moderate to late preterm. Paediatric Respiratory Reviews (10.1016/j.prrv.2026.06.007)
• Kotecha, S. and Watkins, W. J. 2026. Beyond bronchopulmonary dysplasia: early-life determinants and divergent lung function trajectories of prematurity-associated lung disease [Editorial]. Thorax 81 (7), pp.629-630. (10.1136/thorax-2026-225101)
• Lowe, J. et al. 2026. Defining the optimal spirometry cut-off points for optimal bronchodilator response in prematurity-associated lung disease. ERJ Open Research 12 (5)(10.1183/23120541.00239-2026)
• Beaumont, R. N. et al. 2026. Genetic score associations with birthweight in preterm-born infants compared with term-born infants. Scientific Reports 16 15082. (10.1038/s41598-026-45823-4)
• Kotecha, S. J. et al. 2026. Randomised, double-blind, parallel group, placebo-controlled, trial of Bactek for the prevention of lower respiratory tract infections in preterm infants in the UK: BALLOON study - study protocol. BMJ Open 16 (3) e107929. (10.1136/bmjopen-2025-107929)
• Lowe, J. et al. 2026. Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a randomised placebo-controlled trial. Health Technology Assessment 30 (12)(10.3310/gjsk0401)
• Aboklaish, A. F. et al. 2026. Assessment of macrolide resistance in the respiratory tract of preterm-born infants during treatment with azithromycin in the AZTEC clinical trial. Thorax (10.1136/thorax-2025-224094)
• Course, C. W. , Bush, A. and Kotecha, S. 2026. Looking beyond bronchopulmonary dysplasia: prematurity-associated lung disease and its phenotypes. The Lancet Respiratory Medicine 14 (1), pp.60-71. (10.1016/S2213-2600(25)00372-8)
• Duijts, L. et al., 2026. Management of prematurity-associated lung disease from infancy through to adulthood. The Lancet Respiratory Medicine 14 (1), pp.85-98. (10.1016/S2213-2600(25)00369-8)
• Kotecha, S. 2026. Surfactant therapy in severe infant bronchiolitis: evidence from the BESS trial [Comment]. The Lancet Respiratory Medicine 14 (5), pp.380-382. (10.1016/s2213-2600(26)00043-3)

2025

• Cosgrove, E. , Boel, L. and Kotecha, S. 2025. Recent advances in the management of bronchopulmonary dysplasia. Current Treatment Options in Pediatrics 11 (1) 20. (10.1007/s40746-025-00334-8)
• Beaven, M. L. et al., 2025. Physiological responses to exercise in survivors of preterm birth: a meta-analysis. European Respiratory Review 34 (176) 240163. (10.1183/16000617.0163-2024)
• Gibbons, J. T. et al., 2025. Lung volumes, gas transfer and oscillometry after preterm birth: systematic review and meta-analysis. European Respiratory Review 34 (176) 240151. (10.1183/16000617.0151-2024)

2024

• Course, C. W. et al. 2024. Similarities of metabolomic disturbances in prematurity-associated obstructive lung disease to chronic obstructive pulmonary disease. Scientific Reports 14 (1) 23294. (10.1038/s41598-024-73704-1)
• Lowe, J. et al. 2024. Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trial. The Lancet Respiratory Medicine 12 (8), pp.608-618. (10.1016/S2213-2600(24)00079-1)
• Course, C. W. et al. 2024. The respiratory consequences of preterm birth: from infancy to adulthood. British Journal of Hospital Medicine 85 (8), pp.1-11. (10.12968/hmed.2024.0141)
• Lowe, J. et al. 2024. Challenges of modulating the risk of bronchopulmonary dysplasia in clinical trials – Authors' reply. The Lancet Respiratory Medicine 12 (8) E44. (10.1016/S2213-2600(24)00173-5)
• Boel, L. et al., 2024. The role of the airway and gut microbiome in the development of chronic lung disease of prematurity. Pathogens 13 (6) 472. (10.3390/pathogens13060472)
• Kotecha, E. A. , Fitzgerald, D. A. and Kotecha, S. 2024. Adherence in paediatric respiratory medicine: A review of the literature. Paediatric Respiratory Reviews 50 , pp.41-45. (10.1016/j.prrv.2023.09.004)
• Watkins, W. J. et al. 2024. Impact of ambient air pollution on lung function in preterm-born school-aged children. Thorax 79 (6), pp.553-563. (10.1136/thorax-2023-220233)
• Cousins, M. et al. 2024. Intra-breath respiratory mechanics of prematurity-associated lung disease phenotypes in school-aged children. ERJ Open Research 11 (2) 00840. (10.1183/23120541.00840-2024)
• Simpson, S. J. et al., 2024. Unravelling the respiratory health path across the lifespan for survivors of preterm birth. The Lancet Respiratory Medicine 12 (2), pp.167-180. (10.1016/S2213-2600(23)00272-2)
• Gallacher, D. J. et al. 2024. Baseline azithromycin resistance in the gut microbiota of preterm born infants. Pediatric Research 95 , pp.205-212. (10.1038/s41390-023-02743-7)
• Course, C. W. , Kotecha, S. J. and Kotecha, S. 2024. Evolving treatment for prematurity-associated lung disease. Translational Pediatrics 13 (1), pp.1-5. (10.21037/tp-23-505)

2023

• Cousins, M. et al. 2023. Peripheral airway dysfunction in prematurity‐associated obstructive lung disease identified by oscillometry. Pediatric Pulmonology 58 (11), pp.3279-3292. (10.1002/ppul.26658)
• Course, C. W. et al. 2023. Evidence of abnormality in glutathione metabolism in the airways of preterm born children with a history of bronchopulmonary dysplasia. Scientific Reports 13 (1) 19465. (10.1038/s41598-023-46499-w)
• Kotecha, E. et al. 2023. Association of early and current life factors with telomere length in preterm-born children. PLoS ONE 18 (11) e0293589. (10.1371/journal.pone.0293589)
• Isaac, T. C. et al., 2023. Measuring the impact of deprivation on learning difficulties and behaviour among infants born preterm: A cohort study. Journal of Neonatal-Perinatal Medicine 16 (3), pp.411-421. (10.3233/NPM-221151)
• Cousins, M. et al. 2023. Characterising airway obstructive, dysanaptic and PRISm phenotypes of prematurity-associated lung disease. Thorax 78 (9), pp.895-903. (10.1136/thorax-2022-219301)
• Rozycki, H. J. and Kotecha, S. 2023. Domiciliary management of infants and children with chronic respiratory diseases. Paediatric Respiratory Reviews 47 , pp.1-2. (10.1016/j.prrv.2023.04.001)
• Course, C. W. et al. 2023. Characterizing the urinary proteome of prematurity-associated lung disease in school-aged children. Respiratory Research 24 191. (10.1186/s12931-023-02494-3)
• Gibbons, J. T. et al., 2023. Increasing airway obstruction through life following bronchopulmonary dysplasia: a meta-analysis. ERJ Open Research 9 (3) 00046-2023. (10.1183/23120541.00046-2023)
• Course, C. W. et al. 2023. Modulation of pulmonary desmosomes by inhaler therapy in preterm-born children with bronchopulmonary dysplasia. Scientific Reports 13 7330. (10.1038/s41598-023-34233-5)
• Course, C. W. et al. 2023. Association of gestation and fetal growth restriction on cardiovascular health in preterm-born children. Journal of Pediatrics 255 , pp.42-49. (10.1016/j.jpeds.2022.09.057)
• Jee, G. et al., 2023. Early childhood parent-reported speech problems in small and large for gestational age term-born and preterm-born infants: a cohort study. BMJ Open 13 (4) e065587. (10.1136/bmjopen-2022-065587)
• Chan, H. et al., 2023. Image phenotyping of preterm-born children using hyperpolarised 129Xe lung MRI and multiple-breath washout. American Journal of Respiratory and Critical Care Medicine 207 (1), pp.89-90. (10.1164/rccm.202203-0606OC)

2022

• Boel, L. et al., 2022. Non-invasive respiratory support in preterm infants. Paediatric Respiratory Reviews 43 , pp.53-59. (10.1016/j.prrv.2022.04.002)
• Cousins, M. et al. 2022. Impaired exercise outcomes with significant bronchodilator responsiveness in children with prematurity-associated obstructive lung disease. Pediatric Pulmonology 57 (9), pp.2161-2171. (10.1002/ppul.26019)
• Kotecha, S. J. et al. 2022. Geographical differences and temporal improvements in forced expiratory volume in 1 second of preterm-born children. JAMA Pediatrics 176 (9), pp.867-877. (10.1001/jamapediatrics.2022.1990)
• Kotecha, S. J. et al. 2022. Follow-up study of infants recruited to the randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants: study protocol for the AZTEC-FU study. Trials 23 796. (10.1186/s13063-022-06730-x)
• Kotecha, E. et al. 2022. Telomere length in preterm-born children with bronchopulmonary dysplasia (BPD). Presented at: ERS International Congress Barcelona, Spain 4-6 September 2022. Vol. 60.Vol. S66. European Respiratory Society. , pp.1292. (10.1183/13993003.congress-2022.1292)
• Kotecha, S. et al. 2022. Effect of IUGR and catch-up growth on later lung function in preterm children: prospective cohort study. Presented at: ERS International Congress Barcelona, Spain 4-6 September 2022. Vol. 60.Vol. S66. European Respiratory Society. , pp.1186. (10.1183/13993003.congress-2022.1186)
• Kotecha, S. et al. 2022. Systematic review and meta-analysis of FEV1 in preterm born children. Presented at: ERS International Congress Barcelona, Spain 4-6 September 2022. Vol. 60.Vol. S66. European Respiratory Society. , pp.1172. (10.1183/13993003.congress-2022.1172)
• Kotecha, S. et al. 2022. Association of early life factors with prematurity-associated lung disease : prospective cohort study. Presented at: ERS International Congress Barcelona, Spain 4-6 September 2022. Vol. 60.Vol. S66. European Respiratory Society. , pp.1183. (10.1183/13993003.congress-2022.1183)
• Lau, T. M. M. et al. 2022. AZTEC—azithromycin therapy for prevention of chronic lung disease of prematurity: a statistical analysis plan for clinical outcomes. Trials 23 (1) 704. (10.1186/s13063-022-06604-2)
• Hart, K. et al. 2022. Association of early life factors with prematurity-associated lung disease: prospective cohort study. European Respiratory Journal 59 (5) 2101766. (10.1183/13993003.01766-2021)
• Kotecha, S. et al. 2022. Prematurity-associated lung disease: looking beyond bronchopulmonary dysplasia. The Lancet Respiratory Medicine 10 (5) e46. (10.1016/S2213-2600(22)00098-4)
• Goulden, N. , Doull, I. and Kotecha, S. 2022. Inhaled corticosteroids and long-acting β2 receptor agonists for preterm-born children—new insights but still many questions—reply. JAMA Pediatrics 176 (6), pp.615-616. (10.1001/jamapediatrics.2022.0300)
• Goulden, N. et al., 2022. Inhaled corticosteroids alone and in combination with long-acting β2 receptor agonists to treat reduced lung function in preterm-born children: a randomized clinical trial. JAMA Pediatrics 176 (2), pp.133-141. (10.1001/jamapediatrics.2021.5111)

2021

• Chakraborty, M. et al. 2021. nSeP: immune and metabolic biomarkers for early detection of neonatal sepsis-protocol for a prospective multicohort study. BMJ Open 11 (12) e050100. (10.1136/bmjopen-2021-050100)
• Simpson, S. J. et al., 2021. The PELICAN (Prematurity's Effect on the Lungs In Children and Adults Network) ERS clinical research collaboration: understanding the impact of preterm birth on lung health throughout life. European Respiratory Journal 57 (4) 2004387. (10.1183/13993003.04387-2020)
• Bailey, H. D. et al., 2021. Comparison of stillbirth trends over two decades in Wales and Western Australia using pooled routinely collected health data: international retrospective cohort study. Paediatric and Perinatal Epidemiology 35 (3), pp.302-314. (10.1111/ppe.12739)
• Course, C. et al. 2021. Volatile organic compounds as disease predictors in newborn infants: a systematic review. Journal of Breath Research 15 (2) 024002. (10.1088/1752-7163/abe283)

2020

• Lowe, J. et al. 2020. Study protocol: azithromycin therapy for chronic lung disease of prematurity (AZTEC) - a randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants. BMJ Open 10 (10) e041528. (10.1136/bmjopen-2020-041528)
• Kotecha, S. J. et al. 2020. Differential association of air pollution exposure with neonatal and postneonatal mortality in England and Wales: A cohort study. PLoS Medicine 17 (10) e1003400. (10.1371/journal.pmed.1003400)
• Rozycki, H. J. and Kotecha, S. 2020. Covid-19 in pregnant women and babies: what pediatricians need to know.. Paediatric Respiratory Reviews 35 , pp.31-37. (10.1016/j.prrv.2020.06.006)
• Kotecha, S. J. et al. 2020. The effect of catch-up growth in the first year of life on later wheezing phenotypes. European Respiratory Journal 55 (6) 2000884. (10.1183/13993003.00884-2020)
• Gallacher, D. et al. 2020. Dissimilarity of the gut-lung axis and dysbiosis of the lower airways in ventilated preterm infants. European Respiratory Journal 55 (5) 1901909. (10.1183/13993003.01909-2019)
• Duijts, L. et al., 2020. European Respiratory Society guideline on long-term management of children with bronchopulmonary dysplasia.. European Respiratory Journal 55 (1) 1900788. (10.1183/13993003.00788-2019)

2019

• Kotecha, S. , Course, C. and Kotecha, S. 2019. Fractional exhaled nitric oxide in preterm-born subjects: a systematic review and meta-analysis. Presented at: European Respiratory Society International Congress 2018 Paris, France 15-19 September 2018. Vol. 54.Vol. S63. European Respiratory Society. (10.1183/13993003.congress-2019.PA1024)
• Poon, C. Y. et al. 2019. Longitudinal evaluation of myocardial function in preterm infants with respiratory distress syndrome. Echocardiography 36 (9), pp.1713-1726. (10.1111/echo.14462)
• Course, C. W. , Kotecha, S. and Kotecha, S. J. 2019. Fractional exhaled nitric oxide in preterm-born subjects: a systematic review and meta-analysis. Pediatric Pulmonology 54 (5), pp.595-601. (10.1002/ppul.24270)

2018

• Kotecha, S. et al. 2018. Bronchial hyper-responsiveness in preterm-born subjects: A systematic review and meta-analysis. Pediatric Allergy and Immunology 29 (7), pp.715-725. (10.1111/pai.12957)
• Kotecha, S. , Lowe, J. and Kotecha, S. 2018. Effect of foetal and infant growth and body composition on respiratory outcomes in preterm-born children. Paediatric Respiratory Reviews 28 , pp.55-62. (10.1016/j.prrv.2017.12.001)
• Urs, R. et al., 2018. Persistent and progressive long-term lung disease in survivors of preterm birth. Paediatric Respiratory Reviews 28 , pp.87-94. (10.1016/j.prrv.2018.04.001)
• Clemm, H. H. et al., 2018. Bronchial hyper-responsiveness after preterm birth. Paediatric Respiratory Reviews 26 , pp.34-40. (10.1016/j.prrv.2017.06.010)
• Lowe, J. et al. 2018. Effect of fetal and infant growth on respiratory symptoms in preterm-born children. Pediatric Pulmonology 53 (2), pp.189-196. (10.1002/ppul.23920)
• Cousins, M. et al. 2018. Long-term respiratory outcomes following preterm birth. Revista Médica Clínica Las Condes 29 (1), pp.87-97. (10.1016/j.rmclc.2018.02.002)

2017

• Davies, R. et al., 2017. The presentation, clinical features, complications, and treatment of congenital dacryocystocele. Eye 32 , pp.522-526. (10.1038/eye.2017.235)
• Kotecha, S. J. , Chakraborty, M. and Kotecha, S. 2017. Nasal continuous positive airway pressure outperforms heated high-flow nasal cannula therapy as primary respiratory therapy in preterm infants. Evidence-Based Medicine 22 (2), pp.63. (10.1136/ebmed-2016-110618)
• Lowe, J. et al. 2017. Physical activity outcomes following preterm birth. Paediatric Respiratory Reviews 22 , pp.76-82. (10.1016/j.prrv.2016.08.012)

2016

• Kotecha, S. et al. 2016. Effect of early-term birth on respiratory symptoms and lung function in childhood and adolescence. Pediatric Pulmonology 51 (11), pp.1212-1221. (10.1002/ppul.23448)
• Stuchfield, P. , Kotecha, S. and Doull, I. 2016. Antenatal Betamethasone for women at risk for late preterm delivery. New England Journal of Medicine 375 (5), pp.485-487. (10.1056/NEJMc1605902)
• Poon, C. Y. et al., 2016. Pulmonary arterial response to hypoxia in survivors of chronic lung disease of prematurity. Archives of Disease in Childhood-Fetal and Neonatal Edition 101 (4), pp.F309-F313. (10.1136/archdischild-2015-309015)
• Kotecha, S. J. , Gallacher, D. J. and Kotecha, S. 2016. The respiratory consequences of early-term birth and delivery by caesarean sections. Paediatric Respiratory Reviews 19 , pp.49-55. (10.1016/j.prrv.2015.12.002)
• Edwards, M. et al. 2016. Management of prematurity-associated wheeze and its association with atopy. PLoS ONE 11 (5) e0155695. (10.1371/journal.pone.0155695)
• Lowe, J. et al. 2016. Physical activity and sedentary behavior in preterm-born 7-year old children. PLoS ONE 11 (5) e0155229. (10.1371/journal.pone.0155229)
• Watkins, W. J. , Kotecha, S. and Kotecha, S. 2016. All-cause mortality of low birthweight infants in infancy, childhood, and adolescence: population study of England and Wales. PLOS MEDICINE 13 (5) e1002018. (10.1371/journal.pmed.1002018)
• Gallacher, D. , Hart, K. and Kotecha, S. 2016. Common respiratory conditions of the newborn. Breathe 12 (1), pp.30-42. (10.1183/20734735.000716)
• Gallacher, D. J. and Kotecha, S. 2016. Respiratory microbiome of new-born infants. Frontiers in Pediatrics 4 (10), pp.794-802. 00010. (10.3389/fped.2016.00010)

2015

• Smith, C. et al., 2015. Use and safety of azithromycin in neonates: a systematic review. BMJ Open 5 (12) e008194. (10.1136/bmjopen-2015-008194)
• Bolton, C. E. et al., 2015. Republished: Lung consequences in adults born prematurely. Postgraduate Medical Journal 91 (1082), pp.712-718. (10.1136/postgradmedj-2014-206590rep)
• Edwards, M. O. et al. 2015. Early-term birth is a risk factor for wheezing in childhood: a cross-sectional population study. Journal of Allergy and Clinical Immunology 136 (3), pp.581-587.e2. (10.1016/j.jaci.2015.05.005)
• Kotecha, S. J. et al. 2015. Safety and efficacy of high-flow nasal cannula therapy in preterm infants: a meta-analysis. Pediatrics 136 (3), pp.542-555. (10.1542/peds.2015-0738)
• Watts, P. et al., 2015. Visual acuity and associations in children with high hypermetropia. Journal of AAPOS 19 (4), pp.e67-e68. (10.1016/j.jaapos.2015.07.218)
• Bolton, C. E. et al., 2015. Lung consequences in adults born prematurely. Thorax 70 , pp.574-580. (10.1136/thoraxjnl-2014-206590)
• Kotecha, S. J. et al. 2015. The effect of birth weight on lung spirometry in white, school-aged children and adolescents born at term: a longitudinal population based observational cohort study. The Journal of Pediatrics 166 (5), pp.1163-1167. (10.1016/j.jpeds.2015.01.002)
• Lowe, J. et al. 2015. Physical activity in school-age children born preterm. The Journal of Pediatrics 166 (4), pp.877-883. (10.1016/j.jpeds.2014.12.013)
• Pansieri, C. et al., 2015. European survey evaluating the use of azithromycin in neonates. Fundamental and Clinical Pharmacology 29 (S1), pp.43-43. PM2-039. (10.1111/fcp.12106)
• Edwards, M. et al. 2015. Effect of preterm birth on exercise capacity: a systematic review and meta-analysis. Pediatric Pulmonology 50 (3), pp.293-301. (10.1002/ppul.23117)
• Kotecha, S. et al. 2015. Effect of bronchodilators on forced expiratory volume in 1 s in preterm-born participants aged 5 and over: a sytematic review. Neonatology 107 (3), pp.231-240. (10.1159/000371539)

2014

• Chakraborty, M. et al. 2014. Role of serine proteases in the regulation of interleukin-877 during the development of bronchopulmonary dysplasia in preterm ventilated infants. PLoS ONE 9 (12) e114524. (10.1371/journal.pone.0114524)
• Legrand, T. et al., 2014. An optimal LC-MS/MS method for determination of azithromycin in white blood cells: application to pediatric samples. Bioanalysis 6 (17), pp.2317-2328. (10.4155/bio.14.81)
• Paranjothy, S. et al. 2014. Perinatal outcomes and travel time from home to hospital: Welsh data 1995 to 2009. Acta Paediatrica 103 (12), pp.e522-e527. (10.1111/apa.12800)
• Prince, L. R. et al., 2014. Macrophage phenotype is associated with disease severity in preterm infants with chronic lung dsease. PLoS ONE 9 (8) e103059. (10.1371/journal.pone.0103059)
• Lowe, J. et al. 2014. Association between pulmonary Ureaplasma colonization and bronchopulmonary dysplasia in preterm infants: updated systematic review and meta-analysis. The Pediatric Infectious Disease Journal 33 (7), pp.697-702. (10.1097/INF.0000000000000239)
• Pansieri, C. et al., 2014. Ureaplasma, bronchopulmonary dysplasia, and azithromycin in European neonatal intensive care units: a survey. Scientific Reports 4 4076. (10.1038/srep04076)
• Cherian, S. et al., 2014. Oxygen therapy in preterm infants. Paediatric Respiratory Reviews 15 (2), pp.135-141. (10.1016/j.prrv.2012.12.003)
• Edwards, M. et al. 2014. Higher systolic blood pressure with normal vascular function measurements in preterm-born children. Acta Paediatrica 103 (9), pp.904-912. (10.1111/apa.12699)
• Joshi, S. et al., 2014. Cardiovascular function in children who had chronic lung disease of prematurity. Archives of Disease in Childhood. Fetal and neonatal edition 99 (5), pp.F373-F379. (10.1136/archdischild-2013-305185)
• Kotecha, S. 2014. Mini-symposium: oxygen and infancy. Paediatric Respiratory Reviews 15 (2), pp.119. (10.1016/j.prrv.2014.04.012)
• Pickerd, N. et al. 2014. Tidal breathing in preterm infants receiving and weaning from continuous positive airway pressure. The Journal of Pediatrics 164 (5), pp.1058-1063.e1. (10.1016/j.jpeds.2013.12.049)

2013

• Kotecha, S. J. et al. 2013. Effect of preterm birth on later FEV1: a systematic review and meta-analysis. Thorax 68 (8), pp.760-766. (10.1136/thoraxjnl-2012-203079)
• Triantafilou, M. et al. 2013. Synergic activation of Toll-Like Receptor (TLR) 2/6 and 9 in response to ureaplasma parvum & urealyticum in human amniotic epithelial cells. PLoS ONE 8 (4) e61199. (10.1371/journal.pone.0061199)
• Francis, R. J. , Kotecha, S. and Hallett, M. B. 2013. Ca2+ activation of cytosolic calpain induces the transition from apoptosis to necrosis in neutrophils with externalized phosphatidylserine. Journal of Leukocyte Biology 93 (1), pp.95-100. (10.1189/jlb.0412212)
• Chakraborty, M. et al. 2013. Role of interleukin-6, its receptor and soluble gp130 in chronic lung disease of prematurity. Neonatology 104 (3), pp.161-167. (10.1159/000351015)
• Edwards, M. , Kotecha, S. J. and Kotecha, S. 2013. Respiratory distress of the term newborn infant. Paediatric Respiratory Reviews 14 (1), pp.29-37. (10.1016/j.prrv.2012.02.002)
• Kotecha, S. 2013. Should asymptomatic congenital cystic adenomatous malformations be removed? The case against. Paediatric Respiratory Reviews 14 (3), pp.171-172. (10.1016/j.prrv.2013.06.002)
• Kotecha, S. et al. 2013. Increased prevalence of low oligomeric state surfactant protein D with restricted lectin activity in bronchoalveolar lavage fluid from preterm infants. Thorax 68 (5), pp.460-467. (10.1136/thoraxjnl-2012-202729)
• Kotecha, S. et al. 2013. Functional heterogeneity of pulmonary surfactant protein-D in cystic fibrosis. Biochimica et Biophysica Acta - Molecular Basis of Disease 1832 (12), pp.2391-2400. (10.1016/j.bbadis.2013.10.002)
• Parris, T. et al., 2013. Inversion upstream of FOXF1 in a case of lethal alveolar capillary dysplasia with misalignment of pulmonary veins. American Journal of Medical Genetics Part A 161 (4), pp.764-770. (10.1002/ajmg.a.35832)
• Pickerd, N. , Williams, E. M. and Kotecha, S. 2013. Electromagnetic inductance plethysmography to measure tidal breathing in preterm and term infants. Pediatric Pulmonology 48 (2), pp.160-167. (10.1002/ppul.22584)
• Poon, C. , Edwards, M. and Kotecha, S. 2013. Long term cardiovascular consequences of chronic lung disease of prematurity. Paediatric Respiratory Reviews 14 (4), pp.242-249. (10.1016/j.prrv.2012.08.003)
• Poon, C. Y. et al., 2013. Assessment of pulmonary artery pulse wave velocity in children: An MRI pilot study. Magnetic Resonance Imaging 31 (10), pp.1690-1694. (10.1016/j.mri.2013.08.006)
• Triantafilou, K. et al. 2013. Human respiratory syncytial virus viroporin SH: a viral recognition pathway used by the host to signal inflammasome activation. Thorax 68 (1), pp.66-75. (10.1136/thoraxjnl-2012-202182)

2012

• Beeton, M. L. et al. 2012. Serum killing of 'ureaplasma parvum' shows serovar-determined susceptibility for normal individuals and common variable immuno-deficiency patients. Immunobiology 217 (2), pp.187-194. (10.1016/j.imbio.2011.07.009)
• Bolton, C. E. et al., 2012. Are early life factors considered when managing respiratory disease? A British Thoracic Society survey of current practice [Letter]. Thorax 67 (12), pp.1110. (10.1136/thoraxjnl-2012-202637)
• Joshi, S. et al. 2012. Exercise-induced bronchoconstriction in school-aged children who had chronic lung disease in infancy. The Journal of Pediatrics 162 (4), pp.813-818. (10.1016/j.jpeds.2012.09.040)
• Kotecha, S. et al. 2012. Antenatal and postnatal management of congenital cystic adenomatoid malformation. Paediatric Respiratory Reviews 13 (3), pp.162-171. (10.1016/j.prrv.2012.01.002)
• Kotecha, S. et al. 2012. Congenital diaphragmatic hernia. European Respiratory Journal 39 (4), pp.820-829. (10.1183/09031936.00066511)
• Kotecha, S. and Kotecha, S. J. 2012. Long term respiratory outcomes of perinatal lung disease [Editorial]. Seminars in Fetal and Neonatal Medicine 17 (2), pp.65-66. (10.1016/j.siny.2012.01.001)
• Kotecha, S. J. , Dunstan, F. D. and Kotecha, S. 2012. Long term respiratory outcomes of late preterm-born infants. Seminars in Fetal and Neonatal Medicine 17 (2), pp.77-81. (10.1016/j.siny.2012.01.004)

2011

• Beeton, M. L. et al. 2011. Role of pulmonary infection in the development of chronic lung disease of prematurity. European Respiratory Journal 37 (6), pp.1424-1430. (10.1183/09031936.00037810)
• Clark, S. R. et al. 2011. Esterified eicosanoids are acutely generated by 5-lipoxygenase in primary human neutrophils and in human and murine infection. Blood 117 (6), pp.2033-2043. (10.1182/blood-2010-04-278887)
• Francis, R. J. , Kotecha, S. and Hallett, M. B. 2011. Ca2+ events in apoptosis and necrosis of neutrophils [Abstract]. European Journal of Clinical Investigation 41 (s1), pp.46-47. (10.1111/j.1365-2362.2011.02508.x)
• Kotecha, S. J. et al. 2011. Effect of late preterm birth on longitudinal lung spirometry in school age children and adolescents. Thorax 67 (1), pp.54-61. (10.1136/thoraxjnl-2011-200329)
• McGreal, E. P. et al. 2011. Dynamic expression of IL-6 trans-signalling molecules in the lungs of preterm baboons undergoing mechanical ventilation. Neonatology 100 (2), pp.130-138. (10.1159/000322148)
• Poon, C. et al. 2011. Optimization of myocardial deformation imaging in term and preterm infants. European Journal of Echocardiography 12 (3), pp.247-254. (10.1093/ejechocard/jeq192)
• Turner, M. A. , Jacqz-Aigrain, E. and Kotecha, S. 2011. Azithromycin, ureaplasma and chronic lung disease of prematurity: a case study for neonatal drug development. Archives of Disease in Childhood 97 (6), pp.573-577. (10.1136/adc.2010.195180)
• Williams, E. M. et al., 2011. Estimation of tidal ventilation in preterm and term newborn infants using electromagnetic inductance plethysmography. Physiological Measurement 32 (11), pp.1833-1845. (10.1088/0967-3334/32/11/001)

2010

• Kotecha, S. J. et al. 2010. Spirometric lung function in school-age children: Effect of intrauterine growth retardation and catch-up growth. American Journal of Respiratory and Critical Care Medicine 181 (9), pp.969-974. (10.1164/rccm.200906-0897OC)
• Chakraborty, M. , McGreal, E. P. and Kotecha, S. 2010. Acute lung injury in preterm newborn infants: mechanisms and management. Paediatric Respiratory Reviews 11 (3), pp.162-170. (10.1016/j.prrv.2010.03.002)
• Davies, P. L. et al. 2010. Relationship of proteinases and proteinase inhibitors with microbial presence in chronic lung disease of prematurity. Thorax 65 (3), pp.246-251. (10.1136/thx.2009.116061)
• Kotecha, S. et al. 2010. An analysis of the effect of intrauterine growth retardation on spirometric lung function measures of 8-year-old children [Abstract]. Journal of Epidemiology & Community Health 64 (Supp 1), pp.A24. (10.1136/jech.2010.120956.60)
• McGreal, E. P. et al. 2010. Inactivation of IL-6 and soluble IL-6 receptor by neutrophil derived serine proteases in cystic fibrosis. Biochimica et Biophysica Acta - Molecular Basis of Disease 1802 (7-8), pp.649-658. (10.1016/j.bbadis.2010.04.005)
• Poon, C. and Kotecha, S. 2010. Assessment of pulmonary arterial haemodynamics by MRI in children born preterm. Welsh Paediatric Journal 33 , pp.6-8.

2009

• Wall, S. R. et al. 2009. The viral aetiology of croup and recurrent croup. Archives of Disease in Childhood 94 (5), pp.359-360. (10.1136/adc.2008.142984)
• Barbato, A. et al., 2009. Paediatrics in Berlin. European Respiratory Journal 34 (2), pp.436-443. (10.1183/09031936.00038809)
• Beeton, M. L. et al. 2009. Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism. Journal of Antimicrobial Chemotherapy 64 (3), pp.529-538. (10.1093/jac/dkp218)
• Beeton, M. L. et al. 2009. Concurrent titration and determination of antibiotic resistance in 'ureaplasma' species with identification of novel point mutations in genes associated with resistance. Antimicrobial Agents and Chemotherapy 53 (5), pp.2020-2027. (10.1128/AAC.01349-08)
• Joshi, S. et al. 2009. Reproducibility of myocardial velocity and deformation imaging in term and preterm infants. European Journal of Echocardiography 11 (1), pp.44-50. (10.1093/ejechocard/jep161)
• Maxwell, N. C. , Nuttall, D. and Kotecha, S. 2009. Does Ureaplasma spp. cause chronic lung disease of prematurity: ask the audience?. Early Human Development 85 (5), pp.291-296. (10.1016/j.earlhumdev.2008.12.002)
• Pickerd, N. and Kotecha, S. 2009. Pathophysiology of respiratory distress syndrome. Paediatrics and Child Health 19 (4), pp.153-157. (10.1016/j.paed.2008.12.010)

2008

• Davies, P. L. et al. 2008. Monoclonal anti-neutrophil elastase antibody characterisation: ability to block function, detect free versus serpin-complexed enzyme and stain intracellular granules. Journal of Immunological Methods 336 (2), pp.175-182. (10.1016/j.jim.2008.04.010)
• Kotecha, S. 2008. Chronic lung disease of prematurity. In: McIntosh, N. et al., Forfar & Arneil's textbook of pediatrics. 7th ed. Edinburgh: Churchill Livingstone Elsevier. , pp.727-743.
• Miralles, R. , Hodge, R. and Kotecha, S. 2008. Fetal cortisol response to intrauterine microbial colonisation identified by the polymerase chain reaction and fetal inflammation. Archives of Disease in Childhood. Fetal and neonatal edition 93 (1), pp.F51-F54. (10.1136/adc.2006.110130)

2006

• Greenough, K. , Kotecha, S. and Vrijlandt, E. 2006. Bronchopulmonary dysplasia, current models and concepts. In: Frey, U. and Gerritsen, J. eds. Respiratory Diseases in Infants and Children. Respiratory Society Monograph Vol. 37.European Respiratory Society. , pp.217-233. (10.1183/1025448x.00037014)

2004

• Kotecha, S. et al. 2004. Pulmonary Ureaplasma urealyticum is associated with the development of acute lung inflammation and chronic lung disease in preterm infants. Pediatric Research 55 (1), pp.61-8. (10.1203/01.PDR.0000100757.38675.50)

2003

• Kotecha, S. et al. 2003. The role of neutrophil apoptosis in the resolution of acute lung injury in newborn infants. Thorax 58 (11), pp.961-7. (10.1136/thorax.58.11.961)
• Kotecha, S. 2003. Chronic lung disease of prematurity. In: Mackintosh, N. , Helms, P. and Smyth, R. eds. Forfar and Arneil Textbook of Paediatrics (6th ed.). Edinburgh: Churchill Livingstone. , pp.793-798.

2001

• Kotecha, S. et al. 2001. Repeatability of cellular constituents and cytokine concentration in fluid obtained by non-bronchoscopic bronchoalveolar lavage of infants receiving extracorporeal oxygenation. Thorax 56 (12), pp.924-31. (10.1136/thorax.56.12.924)
• Currie, A. E. et al., 2001. Epidermal growth factor in the lungs of infants developing chronic lung disease. European Respiratory Journal 18 (5), pp.796-800. (10.1183/09031936.01.00088201)

1999

• Kotecha, S. 1999. Chronic respiratory complications of neonatal disorders. In: Landau, L. I. and Taussig, L. M. eds. Textbook of paediatric respiratory medicine. Mosby. , pp.488-521.

1994

• Kotecha, S. , Taylor, I. K. and Shaw, R. J. 1994. Pharmalogical modulation of platlet derived growth factor (B) mRNA expresion in human alveolar macrophages. Pulmonary Pharmacology 7 (6), pp.383-391.
• Taylor, I. K. et al., 1994. Platelet derived growth factor (B) mRNA expression in alveolar macrophages in vivo in human asthma. European Respiratory Journal 7 (11), pp.1966-1972.